Clinical Trial: A Phase 1 Clinical Study to Evaluate the Effects of SHR7280 on the Pharmacokinetics of Midazolam, S-warfarin, Omeprazole, Digoxin, and Rosuvastatin in Healthy Subjects

U.S., April 30 -- ClinicalTrials.gov registry received information related to the study (NCT06949124) titled 'A Phase 1 Clinical Study to Evaluate the Effects of SHR7280 on the Pharmacokinetics of Midazolam, S-warfarin, Omeprazole, Digoxin, and Rosuvastatin in Healthy Subjects' on April 22.

Brief Summary: The purpose of this study is to evaluate the effects of SHR7280 on the pharmacokinetics of midazolam, S-warfarin, omeprazole, digoxin and rosuvastatin in healthy subjects.

Study Start Date: April, 2025

Study Type: INTERVENTIONAL

Condition: Endometriosis Uterine Fibroids Assisted Reproduction

Intervention: DRUG: SHR7280 Tablets

SHR7280 tablets.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Jiangsu HengRui Medicine Co., Ltd.

Dis...